作者:Mark A. Dombroski、Michael A. Letavic、Kim F. McClure、John T. Barberia、Thomas J. Carty、Santo R. Cortina、Csilla Csiki、Alan J. Dipesa、Nancy C. Elliott、Christopher A. Gabel、Crystal K. Jordan、Jeff M. Labasi、William H. Martin、Kevin M. Peese、Ingrid A. Stock、Linne Svensson、Francis J. Sweeney、Chul H. Yu
DOI:10.1016/j.bmcl.2003.12.023
日期:2004.2
The synthesis and in vitro p38alpha activity of a novel series of benzimidazolone inhibitors is described. The p38alpha SAR is consistent with a mode of binding wherein the benzimidazolone carbonyl serves as the H-bond acceptor to Met109 of p38alpha in a manner analogous to the pyridine nitrogen of prototypical pyridylimidazole p38 inhibitors. Potent p38alpha activity comparable to that of several previously reported p38 inhibitors is observed for this novel chemotype. (C) 2003 Elsevier Ltd. All rights reserved.